FOLD: Amicus Therapeutics Inc
FOLD exchange rate has changed by 0.07% for today. During the day, the instrument was traded at a low of 14.3200 and at a high of 14.3400.
Follow Amicus Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
FOLD News
- Amicus Therapeutics shareholders approve acquisition by BioMarin Pharmaceutical
- Vertex Gets Rating Upgrade, Earnings Rose Every Quarter This Past Year
- Stocks With Rising Relative Strength: Vertex Pharmaceuticals
- Canaccord raises BioMarin stock price target to $104 on earnings
- Celldex Therapeutics Stock Earns 88 RS Rating
- BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market
- BioMarin posts mixed Q4 results, shares edge lower
- Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues
- BioMarin earnings loom with estimates falling on Voxzogo worries
- Amicus earnings on deck as $4.8B BioMarin deal awaits vote
- What to Expect From These Drug/Biotech Players This Earnings Season?
- Baird maintains BioMarin stock rating amid competitor’s positive trial data
- Should Investors Buy, Sell or Hold Amicus Stock Ahead of Q4 Earnings?
- Amicus to present new data on rare disease treatments at symposium
- Top 3 Health Care Stocks That May Implode In Q1 - Brookdale Senior Living (NYSE:BKD), Amicus Therapeutics (NASDAQ:FOLD)
- The Right Play On BioMarin Pharmaceuticals (NASDAQ:BMRN)
- FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside?
- LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)
- JANX Enters Global Oncology Collaboration With BMY, Stock Rises
- Amicus Therapeutics CEO Campbell sells $1.07 million in shares
Frequently Asked Questions
What is FOLD stock price today?
Amicus Therapeutics Inc stock is priced at 14.3400 today. It trades within 14.3200 - 14.3400, yesterday's close was 14.3300, and trading volume reached 2148. The live price chart of FOLD shows these updates.
Does Amicus Therapeutics Inc stock pay dividends?
Amicus Therapeutics Inc is currently valued at 14.3400. Dividend policy depends on the company, while investors also watch 65.59% and USD. View the chart live to track FOLD movements.
How to buy FOLD stock?
You can buy Amicus Therapeutics Inc shares at the current price of 14.3400. Orders are usually placed near 14.3400 or 14.3430, while 2148 and 0.14% show market activity. Follow FOLD updates on the live chart today.
How to invest into FOLD stock?
Investing in Amicus Therapeutics Inc involves considering the yearly range 8.6200 - 14.3800 and current price 14.3400. Many compare 0.00% and 65.59% before placing orders at 14.3400 or 14.3430. Explore the FOLD price chart live with daily changes.
What are Amicus Therapeutics Inc stock highest prices?
The highest price of Amicus Therapeutics Inc in the past year was 14.3800. Within 8.6200 - 14.3800, the stock fluctuated notably, and comparing with 14.3300 helps spot resistance levels. Track Amicus Therapeutics Inc performance using the live chart.
What are Amicus Therapeutics Inc stock lowest prices?
The lowest price of Amicus Therapeutics Inc (FOLD) over the year was 8.6200. Comparing it with the current 14.3400 and 8.6200 - 14.3800 shows potential long-term entry points. Watch FOLD moves on the chart live for more details.
When did FOLD stock split?
Amicus Therapeutics Inc has gone through stock splits historically. These changes are visible in , 14.3300, and 65.59% after corporate actions.
- Previous Close
- 14.3300
- Open
- 14.3200
- Bid
- 14.3400
- Ask
- 14.3430
- Low
- 14.3200
- High
- 14.3400
- Volume
- 2.148 K
- Daily Change
- 0.07%
- Month Change
- 0.00%
- 6 Months Change
- 65.59%
- Year Change
- 65.59%